Recent advances in living cell nucleic acid probes based on nanomaterials for early cancer diagnosis.
Early cancer diagnosis
In situ detection
Living cell
Nanomaterials
Nucleic acid
Journal
Asian journal of pharmaceutical sciences
ISSN: 2221-285X
Titre abrégé: Asian J Pharm Sci
Pays: Netherlands
ID NLM: 101535338
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
received:
30
06
2023
revised:
16
11
2023
accepted:
05
02
2024
medline:
1
7
2024
pubmed:
1
7
2024
entrez:
1
7
2024
Statut:
ppublish
Résumé
The early diagnosis of cancer is vital for effective treatment and improved prognosis. Tumor biomarkers, which can be used for the early diagnosis, treatment, and prognostic evaluation of cancer, have emerged as a topic of intense research interest in recent years. Nucleic acid, as a type of tumor biomarker, contains vital genetic information, which is of great significance for the occurrence and development of cancer. Currently, living cell nucleic acid probes, which enable the
Identifiants
pubmed: 38948397
doi: 10.1016/j.ajps.2024.100910
pii: S1818-0876(24)00027-8
pmc: PMC11214190
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100910Informations de copyright
© 2024 Shenyang Pharmaceutical University. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.